Valuation

NASA’s portfolio is the definition of lean and mean

The iconic agency – which celebrated the 50th anniversary of putting the first man on the moon last month - is highly selective with the innovations it patents and constantly reviews holdings to eliminate deadweight

NASA’s portfolio is the definition of lean and mean
6 Aug 2019

Record-breaking pharma M&A value disguises plummeting deal-making activity

Abundant biotech funding seems to be empowering small- and medium-sized IP rights holders and driving down acquisition and licensing volume

5 Aug 2019

China seeks to boost IP lending

Companies staked patents and trademarks to borrow $8.5 billion in the first half of 2019. CNIPA and China’s banking regulator want that figure to increase as SMEs face a credit squeeze

Latest

View all
3 Aug 2019

Life sciences IP – the major developments in July

All the big pharma and biotech patent stories from last month in our regular monthly round-up Read more

1 Aug 2019

Expect Pfizer set to focus on more oncology opportunities following off-patent drug purge

After $12 billion Upjohn deal with Mylan, CEO Bourla says company is on the hunt for early- and mid-stage cancer assets Read more

29 Jul 2019

South Korean court asked to sell off IP portfolio seized from Mitsubishi Heavy Industries

Lawyers have requested that patents and trademarks seized from the Japanese company in March be put on the market after it failed to comply with an order to pay compensation to Korean citizens subjected to forced labour during WW2 Read more

23 Jul 2019

It's security, stupid - why it's time to see the wood from the trees in the FTC's case against Qualcomm

If the US chipmaker’s recent court defeat stands then the US risks ceding to China a central role in the development of 5G and future wireless technology Read more

News

View all
12 Jun 2019

IAM and sister publication GDR launch major data event

The Data Business Congress will take place in San Jose, CA, next February with the focus on the capture, protection, management, exploitation and monetisation of one of the pivotal assets of the 21st century Read more

3 Jun 2019

Deloitte makes major IP play with acquisition of top advisory

Big Four firm closes deal to acquire UK-based ClearView in a further sign that IP value creation is moving to the centre of the corporate agenda  Read more

1 Jun 2019

A rotten Apple standard

In a blistering opinion piece, former Vringo chief legal officer David Cohen accuses the iPhone giant of deliberately plotting to destroy SEP licensing Read more

8 May 2019

Over 70 IP business leaders confirmed to speak at IPBC Global 2019

The world's leading event about IP value creation is taking place in Boston at the Westin Waterfront from 16th to 18th June, with over 500 delegates already signed up and space for more limited Read more

Analysis

View all
19 Jul 2019

Alphabet is trimming down its portfolio - but only after sustained growth  

The tech giant saw a steep drop in the number of US patents granted in 2018 after having spent years building its portfolio organically and through strategic acquisitions Read more

16 Jul 2019

Gilead’s unique $5.1 billion licensing deal shows the range of IP monetisation options open to biotech sector

New boss explains that the Big Pharma company will seek out “diverse and creative” asset partnerships – rather than large acquisitions – to boost its pipeline Read more

8 Jul 2019

Bankrupt mobile firm's patents could hit the market soon

It wouldn't be the summer’s biggest auction, but Gionee’s China-heavy smartphone patent portfolio could draw interest from Chinese operating companies and NPEs focused on the market Read more

5 Jul 2019

Get ready for the first CRISPR patent pool

In an exclusive interview, MPEG LA’s Kristin Neuman says that a pool is on its way despite the UCal v Broad stand-off and talks about the future of licensing in biotech’s ‘golden age’ Read more

Insights

View all
1 Oct 2017

A round-up of IP-related quotes, observations and opinions from the recent past …

A round-up of IP-related quotes, observations and opinions from the recent past … Read more

30 Sep 2016

McRO gives hope to US patent owners, but Section 101 uncertainty remains

After two years of uncertainty and no little gloom, a recent Federal Circuit decision may just herald the long-awaited swing-back in the pendulum that software patent owners in the United States have been waiting for. Some, though, still believe that Congress must bite the bullet and take a look at Section 101 Read more

Find an expert

Dawn Hall
Senior Managing Director
New York NY, United States
FTI Consulting Inc